| [1] |
Harrington EK, Roddy GW, West R, et al. Parathyroid hormone/parathyroid hormone-related peptide modulates growth of avian sternal cartilage via chondrocytic proliferation[J]. Anat Rec (Hoboken), 2007, 290(2): 155-167.
|
| [2] |
Borba VZ, Mañas NC. The use of PTH in the treatment of osteoporosis[J]. Arq Bras Endocrinol Metabol, 2010, 54(2): 213-219.
|
| [3] |
Adams SL, Cohen AJ, Lassová L. Integration of signaling pathways regulating chondrocyte differentiation during endochondral bone formation[J]. J Cell Physiol, 2007, 213(3): 635-641.
|
| [4] |
Wang Y H, Liu Y, Buhl K, et al. Comparison of the action of transient and continuous PTH on primary osteoblast cultures expressing differentiation stage-specific GFP[J/OL]. J Bone Miner Res，2005,20(1):5-14. doi: 10.1359/JBMR.041016. |
| [5] |
Fan Y, Hanai JI, Le PT, et al. Parathyroid hormone directs bone marrow mesenchymal cell fate[J]. Cell Metab, 2017, 25(3): 661-672.
|
| [6] |
Yang D, Singh R, Divieti P, et al. Contributions of parathyroid hormone (PTH)/PTH-related peptide receptor signaling pathways to the anabolic effect of PTH on bone[J]. Bone, 2007, 40(6): 1453-1461.
|
| [7] |
O’ Brien MH, Dutra EH, Lima A, et al. PTH [1-34]induced differentiation and mineralization of mandibular condylar cartilage[J/OL]. Sci Rep, 2017, 7(1):3226. doi: 10.1038/s41598-017-03428-y. |
| [8] |
Mohanakrishnan V, Balasubramanian A, Mahalingam G, et al. Parathyroid hormone-induced down-regulation of miR-532-5p for matrix metalloproteinase-13 expression in rat osteoblasts[J]. J Cell Biochem, 2018, 119(7): 6181-6193.
|
| [9] |
Hisa I, Inoue Y, Hendy GN, et al. Parathyroid hormone-responsive Smad3-related factor, Tmem119, promotes osteoblast differentiation and interacts with the bone morphogenetic protein-Runx2 pathway[J]. J Biol Chem, 2011, 286(11): 9787-9796.
|
| [10] |
Takase H, Yano S, Yamaguchi T, et al. Parathyroid hormone upregulates BMP-2 mRNA expression through mevalonate kinase and Rho kinase inhibition in osteoblastic MC3T3-E1 cells[J]. Horm Metab Res, 2009, 41(12): 861-865.
|
| [11] |
Nakao Y, Koike T, Ohta Y, et al. Parathyroid hormone enhances bone morphogenetic protein activity by increasing intracellular 3′，5′-cyclic adenosine monophosphate accumulation in osteoblastic MC3T3-E1 cells[J]. Bone, 2009, 44(5): 872-877.
|
| [12] |
Mansjur KQ, Kuroda S, Izawa T, et al. The effectiveness of human parathyroid hormone and low-intensity pulsed ultrasound on the fracture healing in osteoporotic bones[J]. Ann Biomed Eng, 2016, 44(8): 2480-2488.
|
| [13] |
Kumabe Y, Lee SY, Waki T, et al. Triweekly administration of parathyroid hormone (1-34) accelerates bone healing in a rat refractory fracture model[J/OL]. BMC Musculoskelet Disord, 2017, 18(1): 545. doi: 10.1186/s12891-017-1917-2. |
| [14] |
Lin WP, Lin J. Parathyroid hormone for osteoporosis treatment[J]. Formosan J Musculoskelet Disord, 2011, 2(4):113-117.
|
| [15] |
Cosman F. Parathyroid hormone and abaloparatide treatment for osteoporosis[J]. Curr Opin Endocr Metab Res，2018,3:61-67.
|
| [16] |
Boyce EG, Mai Y, Pham C. Abaloparatide: review of a Next-generation parathyroid hormone agonist[J]. Ann Pharmacother, 2018, 52(5): 462-472.
|
| [17] |
Gonzales MC, Lieb DC, Richardson DW, et al. Recombinant human parathyroid hormone therapy (1-34) in an adult patient with a gain-of-function mutation in the calcium-sensing receptor-a case report[J]. Endocr Pract, 2013, 19(1): e24-e28.
|
| [18] |
Mishra P E, Schwartz B L, Kyriakie S, et al. Short-term PTH(1-34) therapy in children to correct severe hypocalcemia and hyperphosphatemia due to hypoparathyroidism: two case studies[J/OL]. Case Rep Endocrinol，2016,2016:6838626.doi: 10.1155/2016/6838626. |
| [19] |
Goujard C, Salenave S, Briot K, et al. Treating hypoparathyroidism with recombinant human parathyroid hormone. Long-term safety concerns[J/OL]. Lancet, 2020, 395(10232): 1304. doi: 10.1016/S0140-6736(20)30538-9. |
| [20] |
Schalin-Jäntti C, Mornet E, Lamminen A, et al. Parathyroid hormone treatment improves pain and fracture healing in adult hypophosphatasia[J]. J Clin Endocrinol Metab, 2010, 95(12): 5174-5179.
|
| [21] |
Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis[J]. N Engl J Med, 2001, 344(19): 1434-1441.
|
| [22] |
Hadji P, Zanchetta JR, Russo L, et al. The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fractures[J]. Osteoporos Int, 2012, 23(8): 2141-2150.
|
| [23] |
Orwoll ES, Scheele WH, Paul S, et al. The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis[J]. J Bone Miner Res, 2003, 18(1): 9-17.
|
| [24] |
Hinoi E, Ueshima T, Hojo H, et al. Up-regulation of per mRNA expression by parathyroid hormone through a protein kinase A-CREB-dependent mechanism in chondrocytes[J]. J Biol Chem, 2006, 281(33): 23632-23642.
|
| [25] |
Chang JK, Chang LH, Hung SH, et al. Parathyroid hormone 1-34 inhibits terminal differentiation of human articular chondrocytes and osteoarthritis progression in rats[J]. Arthritis Rheum, 2009, 60(10): 3049-3060.
|
| [26] |
Harrington EK, Lunsford LE, Svoboda KK. Chondrocyte terminal differentiation，apoptosis，and type X collagen expression are down-regulated by parathyroid hormone[J]. Anat Rec A Discov Mol Cell Evol Biol, 2004, 281(2): 1286-1295.
|
| [27] |
Harrington EK, Coon DJ, Kern MF, et al. PTH stimulated growth and decreased Col-X deposition are phosphotidylinositol-3，4，5 triphosphate kinase and mitogen activating protein kinase dependent in avian sterna[J]. Anat Rec (Hoboken), 2010, 293(2): 225-234.
|
| [28] |
Liu Q, Wan Q, Yang R, et al. Effects of intermittent versus continuous parathyroid hormone administration on condylar chondrocyte proliferation and differentiation[J]. Biochem Biophys Res Commun, 2012, 424(1): 182-188.
|
| [29] |
Rabie A, Tang GH, Xiong H, et al. PTHrP regulates chondrocyte maturation in condylar cartilage[J]. J Dent Res，2003,82(8):627-631.
|
| [30] |
Rodda SJ, Mcmahon AP. Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors[J]. Development, 2006, 133(16): 3231-3244.
|
| [31] |
Dutra EH, O’Brien MH, Chen PJ, et al. Intermittent parathyroid hormone [1-34] augments chondrogenesis of the mandibular condylar cartilage of the temporomandibular joint[J/OL]. Cartilage, 2019, 2019:1947603519833146. doi: 10.1177/1947603519833146. |
| [32] |
Shi S, Wang C, Acton AJ, et al. Role of sox9 in growth factor regulation of articular chondrocytes[J]. J Cell Biochem, 2015, 116(7): 1391-1400.
|
| [33] |
Hilal G, Massicotte F, Martel-Pelletier J, et al. Endogenous prostaglandin E2 and insulin-like growth factor 1 can modulate the levels of parathyroid hormone receptor in human osteoarthritic osteoblasts[J]. J Bone Miner Res，2001,16(4):713-721.
|
| [34] |
Chen X, Macica CM, Nasiri A, et al. Regulation of articular chondrocyte proliferation and differentiation by Indian hedgehog and parathyroid hormone-related protein in mice[J]. Arthritis Rheum, 2008, 58(12): 3788-3797.
|
| [35] |
Orth P, Cucchiarini M, Zurakowski D, et al. Parathyroid hormone [1-34] improves articular cartilage surface architecture and integration and subchondral bone reconstitution in osteochondral defects in vivo[J]. Osteoarthritis Cartilage，2013,21(4):614-624.
|
| [36] |
Burton DW, Foster M, Johnson KA, et al. Chondrocyte calcium-sensing receptor expression is up-regulated in early Guinea pig knee osteoarthritis and modulates PTHrP, MMP-13, and TIMP-3 expression[J]. Osteoarthritis Cartilage, 2005, 13(5): 395-404.
|
| [37] |
Lugo L, Villalvilla A, Gómez R, et al. Effects of PTH [1-34] on synoviopathy in an experimental model of osteoarthritis preceded by osteoporosis[J]. Osteoarthritis Cartilage, 2012, 20(12): 1619-1630.
|
| [38] |
Caplan AI. Mesenchymal stem cells[J]. J Orthop Res, 1991,9:641-650.
|
| [39] |
Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells[J]. Science, 1999, 284(5411): 143-147.
|
| [40] |
Di Bernardo G, Galderisi U, Fiorito C, et al. Dual role of parathyroid hormone in endothelial progenitor cells and marrow stromal mesenchymal stem cells[J]. J Cell Physiol, 2010, 222(2): 474-480.
|
| [41] |
Mendez-Ferrer S, Michurina TV, Ferraro F, et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche[J]. Nature, 2010, 466(738): 829-834.
|
| [42] |
Sammons J, Ahmed N, El-Sheemy M, et al. The role of BMP-6, IL-6, and BMP-4 in mesenchymal stem cell-dependent bone development: effects on osteoblastic differentiation induced by parathyroid hormone and vitamin D(3)[J]. Stem Cells Dev, 2004, 13(3): 273-280.
|
| [43] |
Pountos I, Georgouli T, Henshaw K, et al. The effect of bone morphogenetic protein-2, bone morphogenetic protein-7, parathyroid hormone, and platelet-derived growth factor on the proliferation and osteogenic differentiation of mesenchymal stem cells derived from osteoporotic bone[J]. J Orthop Trauma, 2010, 24(9): 552-556.
|
| [44] |
Geng S, Zhou S, Glowacki J. Age-related decline in osteoblastogenesis and 1α-hydroxylase/CYP27B1 in human mesenchymal stem cells: stimulation by parathyroid hormone[J]. Aging Cell, 2011, 10(6): 962-971.
|
| [45] |
Yu B, Zhao X, Yang C, et al. Parathyroid hormone induces differentiation of mesenchymal stromal/stem cells by enhancing bone morphogenetic protein signaling[J]. J Bone Miner Res, 2012, 27(9): 2001-2014.
|
| [46] |
Casado-Diaz A, Santiago-Mora R, Quesada JM. The N- and C-terminal domains of parathyroid hormone-related protein affect differently the osteogenic and adipogenic potential of human mesenchymal stem cells[J]. Exp Mol Med, 2010, 42(2): 87-98.
|